Hygieia Group Limited (1650) AI Stock Analysis

• Market Cap: HK$184.00M
• Dividend Yield: 13.16%
• Average Volume (3M): 614.67K
• Price to Earnings (P/E): 18.0
• Beta (1Y): 0.06
• Revenue Growth: 7.94%
• EPS Growth: 18.60%
• Country: HK
• Employees: 2,690
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): <0.01
• Shares Outstanding: 2,000,000,000
• 10 Day Avg. Volume: 535,200
• 30 Day Avg. Volume: 614,666
• PEG Ratio: 0.34
• Price to Book (P/B): 0.92
• Price to Sales (P/S): 0.34
• P/FCF Ratio: 17.10
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 62 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

Hygieia Group Limited's overall stock score reflects a stable financial foundation with strong equity and low leverage. However, profitability margins are under pressure, and technical indicators suggest weak momentum. The high dividend yield is a positive aspect but may also indicate underlying risks.

Hygieia Group Limited Business Overview & Revenue Model

Company Description

Hygieia Group Limited, an investment holding company, provides general cleaning services in Singapore and Thailand. The company offers general cleaning works for various public and private venues, including medical centres, shopping malls, commercial and industrial buildings, schools, hotels, and private condominiums, as well as public access areas in town councils. It also provides general cleaning works for private customers at private residences, an office, and industrial buildings. The company was founded in 1991 and is headquartered in Singapore. Hygieia Group Limited is a subsidiary of TEK Assets Management Limited.

How the Company Makes Money

Hygieia Group Limited generates revenue through a multifaceted business model that includes the sale of medical devices, subscription services for software applications, and consulting services in healthcare analytics. Key revenue streams consist of direct sales of their proprietary healthcare products and licensing agreements for their software solutions. Additionally, the company benefits from partnerships with healthcare institutions and technology firms that enhance its market reach and product offerings. The increasing demand for telehealth solutions and data-driven healthcare services also contributes significantly to its earnings, given the growing emphasis on patient-centered care and the digital transformation of the healthcare industry.

Hygieia Group Limited Financial Statement Overview

Summary

Hygieia Group Limited demonstrates a solid financial foundation with strong equity and low leverage, providing stability. However, profitability margins are under pressure, indicating a need for operational improvements. Cash flow generation is healthy, though there is potential to enhance free cash flow.

Income Statement

The company has shown a consistent increase in revenue over the past years, with a notable revenue growth rate of 12.27% from 2023 to 2024. Gross profit margin improved slightly to 12.91% in 2024, indicating better cost management. However, the net profit margin remains low at 1.01%, suggesting challenges in converting revenue into profit. The EBIT and EBITDA margins are also relatively low, reflecting potential inefficiencies in operations.

Balance Sheet

The balance sheet reflects a strong equity position with an equity ratio of 67.87% in 2024, indicating financial stability. The debt-to-equity ratio is low at 0.14, suggesting conservative leverage. Return on equity improved to 2.72%, but remains modest, highlighting room for enhancing shareholder returns.

Cash Flow

Operating cash flow has improved, with a positive free cash flow growth rate of 2.74% from 2023 to 2024. The operating cash flow to net income ratio is 2.87, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio is 1.98, suggesting that while cash flow is positive, there is limited free cash flow relative to net income.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	74.70M	66.54M	63.42M	71.61M	72.61M
Gross Profit	9.65M	8.99M	8.60M	14.45M	22.16M
EBITDA	516.00K	3.24M	1.48M	9.02M	12.38M
Net Income	756.00K	454.00K	-1.60M	5.14M	8.80M
Balance Sheet
Total Assets	40.99M	44.48M	46.87M	56.53M	50.16M
Cash, Cash Equivalents and Short-Term Investments	18.43M	22.58M	27.52M	31.02M	22.63M
Total Debt	3.90M	6.04M	7.52M	9.47M	7.45M
Total Liabilities	13.06M	14.38M	15.27M	18.84M	17.57M
Stockholders Equity	27.82M	30.05M	31.60M	37.70M	32.55M
Cash Flow
Free Cash Flow	1.50M	146.00K	4.14M	8.79M	6.58M
Operating Cash Flow	2.17M	1.04M	5.08M	9.87M	7.22M
Investing Cash Flow	2.60M	-815.00K	-10.41M	1.72M	-3.11M
Financing Cash Flow	-6.64M	-5.52M	-8.19M	-675.00K	3.43M

Hygieia Group Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.09
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1650, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.09, and above the 200-day MA of 0.07, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.69 is Neutral, neither overbought nor oversold. The STOCH value of 30.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1650.

Hygieia Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1650	62 Neutral	HK$184.00M	18.04	6.39%	13.16%	7.94%	18.60%
1376	56 Neutral	HK$355.00M	-57.26	-50.55%	―	1.93%	-158.33%
8501	49 Neutral	HK$89.07M	-22.61	-2.99%	―	-2.17%	-188.41%
3893	46 Neutral	HK$147.43M	-4.78	―	―	-24.93%	-69.61%
1867	43 Neutral	HK$277.88M	-5.46	-52.87%	―	-38.54%	-150.00%
8455	41 Neutral	HK$48.00M	-3.09	295.72%	―	-8.22%	-7.28%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

Hygieia Group Limited Corporate Events

Hygieia Group Limited Appoints New Independent Non-Executive Director

Hygieia Group Limited has announced the appointment of Mr. Leung as an independent non-executive director. Mr. Leung has confirmed his independence according to the Listing Rules, with no financial or other interests in the company, ensuring no factors affect his independence at the time of his appointment.

Hygieia Group Limited Updates Final Dividend Payment Details

Hygieia Group Limited announced an update regarding its cash dividend for the financial year ending 31 December 2024. The final ordinary dividend declared is SGD 0.002 per share, equivalent to HKD 0.012108 per share, with the payment date set for 06 June 2025. This update includes details on the exchange rate and currency in which the dividend will be paid, reflecting the company’s commitment to maintaining shareholder value.

Hygieia Group Limited’s AGM Resolutions Unanimously Approved

Hygieia Group Limited announced that all proposed resolutions at its annual general meeting held on May 15, 2025, were passed unanimously. These resolutions included the approval of financial statements, declaration of a final dividend, re-election of directors, and granting of mandates to issue and buy back shares. The unanimous approval reflects strong shareholder support and may positively impact the company’s governance and market operations.